The p53 pathway in hematopoiesis: Lessons from mouse models, implications for humans

115Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aberrations in the p53 tumor suppressor pathway are associated with hematologic malignancies. p53-dependent cell cycle control, senescence, and apoptosis functions are actively involved in maintaining hematopoietic homeostasis under normal and stress conditions. Whereas loss of p53 function promotes leukemia and lymphoma development in humans and mice, increased p53 activity inhibits hematopoietic stem cell function and results in myelodysplasia. Thus, exquisite regulation of p53 activity is critical for homeostasis. Most of our understanding of p53 function in hematopoiesis is derived from genetically engineered mice. Here we summarize some of these models, the various mechanisms that disrupt the regulation of p53 activity, and their relevance to human disease. © 2012 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Pant, V., Quintás-Cardama, A., & Lozano, G. (2012, December 20). The p53 pathway in hematopoiesis: Lessons from mouse models, implications for humans. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-05-356014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free